Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading

European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading

MT newswireMT newswire2026/10/06 15:11

11:11 AM EDT, 10/06/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher late Tuesday morning, rising 0.74% to 1,902.48 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by medical device maker EDAP TMS (FOCL) and telecommunications company Nokia (NOK), which rose 5.9% and 4.2% respectively. They were followed by software firm SAP (SAP) and biotech firm Evaxion (EVAX), which were up 2.5% and 0.4% respectively. The decliners from continental Europe were led by accommodations booking site trivago (TRVG) and biopharmaceutical company Cellectis (CLLS), which fell 5% and 2.8% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and pharmaceutical company Novo Nordisk (NVO), which were down 3.6% and 1.2% respectively. The gainers from the UK were led by biotech company Trinity Biotech (TRIB) and lender Lloyds Banking Group (LYG), which climbed 3.5% and 2.1% respectively. They were followed by communications company WPP (WPP) and alcoholic beverage company Diageo (DEO), which increased 1.4% and 1.3% respectively. The decliners from the UK and Ireland were led by biopharmaceutical company Bicycle Therapeutics (BCYC) and biotech firm Autolus Therapeutics (AUTL), which decreased 3% and 2.2% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and pharmaceutical company Silence Therapeutics (SLN), which lost 0.5% and 0.1% respectively.

11:11 AM EDT, 10/06/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher late Tuesday morning, rising 0.74% to 1,902.48 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by medical device maker EDAP TMS (FOCL) and telecommunications company Nokia (NOK), which rose 5.9% and 4.2% respectively. They were followed by software firm SAP (SAP) and biotech firm Evaxion (EVAX), which were up 2.5% and 0.4% respectively. The decliners from continental Europe were led by accommodations booking site trivago (TRVG) and biopharmaceutical company Cellectis (CLLS), which fell 5% and 2.8% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and pharmaceutical company Novo Nordisk (NVO), which were down 3.6% and 1.2% respectively. The gainers from the UK were led by biotech company Trinity Biotech (TRIB) and lender Lloyds Banking Group (LYG), which climbed 3.5% and 2.1% respectively. They were followed by communications company WPP (WPP) and alcoholic beverage company Diageo (DEO), which increased 1.4% and 1.3% respectively. The decliners from the UK and Ireland were led by biopharmaceutical company Bicycle Therapeutics (BCYC) and biotech firm Autolus Therapeutics (AUTL), which decreased 3% and 2.2% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and pharmaceutical company Silence Therapeutics (SLN), which lost 0.5% and 0.1% respectively.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Elon Musk reportedly contacts TSMC, Intel CEO Pat Gelsinger quickly responds: Terafab collaboration continues

Intel (INTC.US) CEO Patrick Gelsinger stated that the company will continue its collaboration with Elon Musk on the Terafab project.

智通财经•2026/10/07 09:08

BUZZ-SpaceX seeks 40 billions USD in financing to purchase Nvidia chips, stock price drops in response

October 7 - SpaceX (SPCX.O) shares fell 1.8% in premarket trading to $168.9. According to the Financial Times, citing people familiar with the matter, the company plans to raise $40 billions to acquire Nvidia (NVDA.O) AI chips. The Financial Times reports that the proposed financing, led by Apollo Global Management (APO.N), includes around $10 billions in bank loans and $30 billions in investment-grade bonds to pay for the chip orders. This move by Elon Musk's company underscores the enormous capital required amid the AI boom, as tech companies race to expand their computing infrastructure. SpaceX, Apollo Global Management, and Nvidia have yet to respond to Reuters' requests for comment. Out of 41 brokerages, 32 have a "Buy" or higher rating on the stock, 6 rate it "Hold," and 3 as "Sell" or lower; the median target price is $217, according to data compiled by London Stock Exchange Group (LSEG). As of the previous trading session close, SPCX shares have risen 27.3% from their IPO price of $135.

路透社•2026/10/07 08:51

BUZZ - Constellation Brands shares fall after lowering profit margin expectations

October 7 - Constellation Brands (STZ.N) shares fell nearly 5% in pre-market trading to $110.11. The Corona beer maker lowered its full-year operating margin forecast to 31%-32% from the previous 32%-33%. The company reported Q2 profit and sales on Tuesday that exceeded expectations, driven by strong demand for beers such as Modelo Especial and Victoria, which helped offset challenges in the alcohol sector amid weak consumption. JPMorgan stated that Q2 FY2027 financial results were largely in line with expectations; market focus may turn to management's outlook for H2 FY2027 beer business revenue and operating margins, and the implications for FY2028. The company will pay $75 million to acquire the vodka-based ready-to-drink (RTD) brand SpikedAde upon transaction completion, with up to a further $278 million over five years depending on brand performance and capital allocation priorities. “Although the brand and category are still nascent, the acquisition of SpikedAde could hold significant potential,” said JPMorgan. As of yesterday's close, the stock is down 16% year to date.

路透社•2026/10/07 08:51